Covaxin safe for children between 2-18 years

Bharat Biotech today announced that BBV152 (Covaxin), its whole-virion inactivated Covid-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study.

Bharat Biotech had conducted phase II/III, open-label, and multicenter studies to evaluate the safety, reactogenicity, and immunogenicity of Covaxin in healthy children and adolescents in the 2-18 age group.

The clinical trials conducted in the paediatric population between June 2021 and September 2021 have shown robust safety, reactogenicity, and immunogenicity. The data was submitted to the Central Drugs Standard Control Organisation (CDSCO) in October 2021, and received emergency-use nod for children aged 12-18 from DCGI recently.

In the study, no serious adverse event was reported. 374 subjects reported either mild or moderate severity symptoms with 78.6 per cent getting resolved within one day. Pain at the injection site was the most commonly reported adverse event.

Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech, said, “Covaxin’s clinical trial data from the paediatric population is very encouraging. Safety of the vaccine is critical for children and we are glad to share that Covaxin has now proven data for safety and immunogenicity in children. We have now achieved our goal of developing a safe and efficacious Covid-19 vaccine for adults and children. Vaccines are a great preventive tool; the power of vaccines can only be harnessed if used prophylactically.”


Next Story :

  • Rajasthani Film ‘Bharkhama’ Won Special Jury Mention at JIFF 2025

    Rajasthani Film ‘Bharkhama’ Won Special Jury Mention at JIFF 2025

    The Rajasthani film Bharkhama made waves at the Jaipur International Film Festival (JIFF) 2025, earning the distinguished Special Jury Mention Award. The movie’s special screening at GT Inox, Malviya Nagar, Jaipur, left a profound impact on both viewers and critics, marking a significant moment for regional cinema. The event was further elevated by the presence…


  • Trump Launches $500 Billion “Stargate” AI Venture 

    Trump Launches $500 Billion “Stargate” AI Venture 

    In a major push to advance artificial intelligence (AI) infrastructure, United States President Donald Trump revealed a $100 billion joint venture called “Stargate” on January 21 (January 22 IST). The initiative, spearheaded by SoftBank Group, OpenAI, and Oracle Corporation, aims to revolutionize AI development in the U.S. with plans to scale the investment to $500…


  • Dalit Groom Riding Horse Faces Opposition: Police Step in for Protection

    Dalit Groom Riding Horse Faces Opposition: Police Step in for Protection

    In Lavera village of Srinagar block, Ajmer district, a wedding procession proceeded peacefully on January 21 under heavy police protection. Around 400 police personnel were deployed to prevent potential opposition from upper-caste locals, who reportedly objected to the groom riding a horse—an act traditionally viewed as a symbol of status and equality.


  • Beti Bachao Beti Padhao Marks 10 Years of Launch

    Beti Bachao Beti Padhao Marks 10 Years of Launch

    As India marks the tenth anniversary of the Beti Bachao Beti Padhao (BBBP) initiative, Prime Minister Narendra Modi has hailed the program’s transformative impact on addressing gender disparities and empowering the girl child. Launched on January 22, 2015, the initiative has evolved into a landmark movement for gender equality and girl-child education in India.


  • JEE Mains Exam: 3 Students Denied Entry for Arriving Late

    JEE Mains Exam: 3 Students Denied Entry for Arriving Late

    The JEE Mains exams, necessary for admissions in prestigious engineering colleges across India, began on Wednesday, attracting thousands of eager students to exam centers nationwide. However, three students at the Ion Digital Zone Exam Center in Visakhapatnam were denied entry for arriving late.


Now you can get latest stories from Indtoday on Telegram everyday. Click the link to subscribe.  Click to follow Indtoday Facebook page and Twitter and on Instagram. For all the latest Hyderabad News updates

Leave A Reply

Your email address will not be published.